Authors:
Bielawski, K
Zaczek, A
Lisowska, U
Dybikowska, A
Kowalska, A
Falkiewicz, B
Citation: K. Bielawski et al., The suitability of DNA extracted from formalin-fixed, paraffin-embedded tissues for double differential polymerase chain reaction analysis, INT J MOL M, 8(5), 2001, pp. 573-578
Citation: K. Bielawski et al., DNA-Binding activity and cytotoxicity of the extended diphenylfuran bisamidines in breast cancer MCF-7 cells, BIOL PHAR B, 24(6), 2001, pp. 704-706
Citation: K. Bielawski et al., Aromatic extended bisamidines: Synthesis, inhibition of topoisomerases, and anticancer cytotoxicity in vitro, ARCH PHARM, 334(7), 2001, pp. 235-240
Authors:
Bartulewicz, D
Bielawski, K
Bielawska, A
Rozanski, A
Citation: D. Bartulewicz et al., Synthesis, molecular modelling, and antiproliferative and cytotoxic effects of carbocyclic derivatives of distamycin with chlorambucil moiety, EUR J MED C, 36(5), 2001, pp. 461-467
Citation: A. Bielawska et al., DNA-binding properties and cytotoxicity activity of novel aromatic amidines in cultured human skin fibroblasts, PHARMAZIE, 56(5), 2001, pp. 428-429
Authors:
Bielawska, A
Chrzanowski, K
Bielawski, K
Palka, J
Citation: A. Bielawska et al., Decreased cytotoxicity and increased antimitotic activity of a proline analogue of chlorambucil as a prodrug susceptible to the action of fibroblast's prolidase, PHARMAZIE, 56(4), 2001, pp. 290-294
Authors:
Furmanek, B
Kaczorowski, T
Bugalski, R
Bielawski, K
Bohdanowicz, J
Podhajska, AJ
Citation: B. Furmanek et al., Identification, characterization and purification of the lantibiotic staphylococcin T, a natural gallidermin variant. (vol 87, pg 856, 1999), J APPL MICR, 88(1), 2000, pp. 190-190
Authors:
Bielawska, A
Bielawski, K
Chrzanowski, K
Wolczynski, S
Citation: A. Bielawska et al., Prolidase-activated prodrug for cancer chemotherapy - Cytotoxic activity of proline analogue of chlorambucil in breast cancer MCF-7 cells, FARMACO, 55(11-12), 2000, pp. 736-741
Authors:
Bielawski, K
Bielawska, A
Bartulewicz, D
Rozanski, A
Citation: K. Bielawski et al., Molecular modelling of the interaction of carbocyclic analogues of netropsin and distamycin with d(CGCGAATTCGCG)(2), ACT BIOCH P, 47(3), 2000, pp. 855-866
Authors:
Falkiewicz, B
Schlotter, CM
Bosse, U
Bielawski, K
Vogt, U
Citation: B. Falkiewicz et al., c-myc Oncogene gene dosage, serum CEA and CA-15.3 antigen levels, and cellular DNA values in relation to ex vivo chemosensitivity of primary human breast cancer, ACT BIOCH P, 47(1), 2000, pp. 149-156
Authors:
Vogt, U
Falkiewicz, B
Bielawski, K
Bosse, U
Schlotter, CM
Citation: U. Vogt et al., Relationship of c-myc and erbB oncogene family gene aberrations and other selected factors to ex vivo chemosensitivity of ovarian cancer in the modified ATP-chemosensitivity assay, ACT BIOCH P, 47(1), 2000, pp. 157-164
Authors:
Furmanek, B
Kaczorowski, T
Bugalski, R
Bielawski, K
Bogdanowicz, J
Podhajska, AJ
Citation: B. Furmanek et al., Identification, characterization and purification of the lantibiotic staphylococcin T, a natural gallidermin variant, J APPL MICR, 87(6), 1999, pp. 856-866
Authors:
Vogt, U
Bielawski, K
Schlotter, CM
Bosse, U
Falkiewicz, B
Podhajska, AJ
Citation: U. Vogt et al., Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer, GENE, 223(1-2), 1998, pp. 375-380